Cutting-Edge Research. Translational Science.

Company Presentation:
BIO 2025, June 19, 10:30 AM in Room 153B,
Boston Convention and Exhibition Center

• CorriXR Therapeutics Appoints Jan Case as Chief Operating Officer

• Publication: Business Wire

• 4 companies to watch in the accelerating gene editing race

  Publication: PharmaVoice

• CorriXR Therapeutics Names Eric Kmiec Chief Executive Officer

  Publication: Business Wire

• CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors

  Publication: Business Wire

• Precision Medicine in Delaware: Working to treat every body according to its genetic makeup

  Publication: Delaware Business Times

• RealLIST Connectors 2024: Meet 20 of the most impactful leaders in Delaware’s innovation scene

  Publication: Technical.ly

• CorriXR: How This Company Is Using CRISPR/Cas Gene Editing To Develop New Medicines

  Publication: Pulse 2.0

• RealLIST Startups 2024: Delaware’s most promising early-stage companies

  Publication: Technical.ly

• CorriXR sees investment from Oklahoma investment firm

  Publication: Delaware Business Times

• Therapeutic Gene Editing: A Lot Done, a Lot More to Do. Interview with Eric Kmiec, Ph.D.

  Publication: CRISPR Medicine News

• Cortado Ventures Invests in CorriXR

  Source: Cortado Ventures

• ChristianaCare spinout CorriXR is off to the races

  Publication: Technical.ly

• CorriXR Therapeutics names Moorad as new CEO

  Publication: Delaware Business Times

• CorriXR Therapeutics Announces Deborah Moorad as Its New Chief Executive Officer

  Publication: Business Wire

• Eric Kmiec, Ph.D., Named Editor-in-Chief of Gene and Genome Editing

  Publication: ChristianaCare News

• Education & Healthcare: Collaborating on the Path to Innovation

  Publication: Innovation Delaware - Delaware Business Times Special Edition

• Delaware leads in gene-editing CRISPR tech

  Publication: Delaware Business Times

• Delaware BioScience Association Announces Most Promising New Company Competition Winner

  Publication: Delaware BioScience Association

• CorriXR Therapeutics wins inaugural Delaware DNA pitch contest 

  Publication: Delaware Business Times

• CRISPR : Can it Cure Disease or is it Playing God?

  Podcast: The Smartest Doctor in the Room

• This CRISPR Researcher Says Gene Editing Isn't Playing God

  Publication: Futurism

• Profiles in Innovation: Dr. Eric Kmiec

  Publication: Choose Delaware

• ChristianaCare explores using CRISPR in cancer treatment, starts talks with FDA

  Publication: The Cancer Letter

• ChristianaCare Spins Out First Commercial Gene Editing Biotechnology Start-Up Company, CorriXR Therapeutics

  Publication: ChristianaCare News

• CRISPR Makes Resistant Lung Cancer Cells Vulnerable to Chemotherapy

  Publication: CRISPR Medicine News

• Gene Editing: Making the Impossible Possible with Drs. Eric Kmiec & Natalia Rivera-Torres

  Podcast: Lungcast with the American Lung Association

• CRISPR-Induced Gene Products Control Response to Therapy in Lung Cancer Cells

  Publication: Genetic Engineering News

• Scientists Put CRISPR on Safer Path to Patient Treatments With New Way to Evaluate Impacts of Gene Edits

  Publication: ChristianaCare News

• Unlike at Other Labs, Women Scientists Thrive at ChristianaCare’s Gene Editing Institute

  Publication: ChristianaCare News